title: Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study.
abstract: OBJECTIVE
  To compare cardiovascular risk among women with high normal blood pressure (130-9/85-9 mm Hg) against those with normal blood pressure (120-9/75-84 mm Hg) and those with baseline hypertension.
  
  
  METHODS
  Prospective cohort study.
  
  
  METHODS
  Women's health study, United States.
  
  
  METHODS
  39 322 initially healthy women classified into four categories according to self reported baseline blood pressure and followed for a median of 10.2 years.
  
  
  METHODS
  Time to cardiovascular death, myocardial infarction, or stroke (major cardiovascular event-primary end point); progression to hypertension.
  
  
  RESULTS
  982 (2.5%) women developed a major cardiovascular event, and 8686 (30.1%) women without baseline hypertension progressed to hypertension. The age adjusted event rate for the primary end point was 1.6/1000 person years among women with normal blood pressure, 2.9/1000 person years among those with high normal blood pressure, and 4.3/1000 person years among those with baseline hypertension. Compared with women with high normal blood pressure (reference group), those with normal blood pressure had a lower risk of a major cardiovascular event (adjusted hazard ratio 0.61, 95% confidence interval 0.48 to 0.76) and of incident hypertension (0.42, 0.40 to 0.44). The hazard ratio for a major cardiovascular event in women with baseline hypertension was 1.30 (1.08 to 1.57). Women who progressed to hypertension (reference group) during the first 48 months of the study had a higher cardiovascular risk than those who remained normotensive (adjusted hazard ratio 0.64, 0.50 to 0.81). Women with high normal blood pressure at baseline who progressed to hypertension (reference group) had similar outcome rates to women with baseline hypertension (adjusted hazard ratio 1.17, 0.88 to 1.55).
  
  
  CONCLUSIONS
  The cardiovascular risk of women with high normal blood pressure is higher than that of women with normal blood pressure. The cardiovascular risk of women who progress to hypertension is increased shortly after a diagnosis of hypertension has been made.
  
  
  BACKGROUND
  Clinical trials NCT00000479 [ClinicalTrials.gov].
authors: Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 900 Commonwealth Avenue, Boston, MA 02215, USA. conend@uhbs.ch
authors: David
authors: D
authors: Conen
authors: Paul M
authors: PM
authors: Ridker
authors: Julie E
authors: JE
authors: Buring
authors: Robert J
authors: RJ
authors: Glynn
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000502:physiology*; D002423:Cause of Death; D015331:Cohort Studies; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000401:mortality* / Q000503:physiopathology; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D020521:Stroke / Q000401:mortality*
chemical_list: D000959:Antihypertensive Agents
references: Lancet. 2002 Dec 14;360(9349):1903-13
references: 12493255
references: JAMA. 2003 Apr 23-30;289(16):2083-93
references: 12709466
references: JAMA. 2003 May 21;289(19):2560-72
references: 12748199
references: N Engl J Med. 2004 Apr 1;350(14):1387-97
references: 15070788
references: Am J Epidemiol. 1977 Oct;106(4):306-13
references: 910798
references: Am J Epidemiol. 1986 May;123(5):894-900
references: 3962971
references: J Hypertens. 1994 Jun;12(6):703-8
references: 7963496
references: Arch Intern Med. 1997 Mar 24;157(6):657-67
references: 9080920
references: N Engl J Med. 1997 Apr 17;336(16):1117-24
references: 9099655
references: Lancet. 2005 Jan 15-21;365(9455):217-23
references: 15652604
references: N Engl J Med. 2005 Mar 31;352(13):1293-304
references: 15753114
references: Circulation. 2005 Apr 19;111(15):1992-8
references: 15837954
references: JAMA. 2005 Jul 6;294(1):56-65
references: 15998891
references: J Am Coll Cardiol. 2005 Sep 6;46(5):743-51
references: 16139119
references: Am J Med. 2006 Feb;119(2):133-41
references: 16443415
references: Ann Intern Med. 2006 Apr 4;144(7):485-95
references: 16585662
references: N Engl J Med. 2006 Apr 20;354(16):1685-97
references: 16537662
references: N Engl J Med. 2006 Jun 1;354(22):2368-74
references: 16738273
references: Ann Intern Med. 2006 Jul 4;145(1):1-11
references: 16818923
references: Ann Intern Med. 2006 Jul 4;145(1):21-9
references: 16818925
references: J Gen Intern Med. 2007 May;22(5):606-13
references: 17370032
references: BMJ. 2007 Apr 28;334(7599):885-8
references: 17449506
references: J Hypertens. 2007 Jun;25(6):1105-87
references: 17563527
references: Ann Intern Med. 2002 Apr 2;136(7):493-503
references: 11926784
references: J Natl Cancer Inst. 1999 Dec 15;91(24):2102-6
references: 10601381
references: J Womens Health Gend Based Med. 2000 Jan-Feb;9(1):19-27
references: 10718501
references: N Engl J Med. 2001 Jan 4;344(1):3-10
references: 11136953
references: N Engl J Med. 2001 May 3;344(18):1343-50
references: 11333990
references: N Engl J Med. 2001 Nov 1;345(18):1291-7
references: 11794147
references: Lancet. 2001 Nov 17;358(9294):1682-6
references: 11728544
references: Hypertension. 2002 Jan;39(1):105-10
references: 11799087
references: JAMA. 2002 Feb 27;287(8):1003-10
references: 11866648